This study developed an innovative immune prognostic model for evaluating the prognosis of MCL patients, integrating immune factors with existing clinical features to improve prognostic evaluation.
Hao et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: